Physician profile
Kompal Gadh
NPI 1235118399
$3,884.95
in general payments reported to CMS, 2019-2025
38 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $712 · 2021: $901 · 2022: $491 · 2023: $705 · 2024: $346 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.08 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $718.43 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $471.32 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $224.78 | 2019-2025 | |
| Therapeuticsmd, INC. | $193.51 | 2019-2021 | |
| Evofem Biosciences, INC. | $193.33 | 2021-2025 | Phexxi, Solosec, Phexx |
| Avion Pharmaceuticals | $175.42 | 2019-2023 | Balcoltra |
| Coopersurgical, INC. | $171.84 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $169.87 | 2023-2025 | Veozah |
| Allergan, INC. | $167.12 | 2019-2020 | |
| Daiichi Sankyo INC. | $131.83 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $126.52 | 2019 | |
| Exeltis, USA INC. | $102.96 | 2022-2025 | Slynd |
| Mission Pharmacal Company | $94.82 | 2019-2024 | Ferralet 90 |
| Lupin INC. | $86.48 | 2019-2020 | |
| Hologic Sales and Service, LLC | $84.85 | 2019-2023 | Affirm Prone Biopsy System, Aptima |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $83.59 | 2023-2025 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $68.56 | 2020 | |
| Mylan Pharmaceuticals INC. | $66.08 | 2020-2021 | |
| Shield Therapeutics INC | $57.54 | 2024 | |
| Optumhealth Care Solutions, LLC | $54.96 | 2023 | Vivify Health Care Team Portal |
| Organon LLC | $47.41 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $42.49 | 2021-2022 | |
| Millicent US INC | $41.18 | 2024 | Femring, Intrarosa |
| Pfizer INC. | $40.60 | 2021-2023 | |
| Roche Diagnostics Corporation | $28.06 | 2021 | |
| Medicem INC. | $24.89 | 2020 | |
| Duchesnay USA Incorporated | $23.86 | 2019 | |
| Ethicon US, LLC | $23.82 | 2024 | Dermabond Prineo |
| Smith+Nephew, INC. | $22.76 | 2022 | |
| Axonics, INC. | $20.62 | 2023 | Axonics |
| Agile Therapeutics, INC. | $20.12 | 2021 | |
| Channel Medsystems, INC. | $17.43 | 2025 | |
| Amag Pharmaceuticals, INC. | $17.43 | 2019 | |
| Solventum Corporation | $16.47 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Scynexis, INC. | $15.70 | 2022 | |
| Gynesonics, INC. | $13.53 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Dysis Medical, INC. | $12.91 | 2020 | |
| Myovant Sciences INC. | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kompal Gadh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.